The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy.
Ioanna PyromaliLaurence RichardPaco DerouaultJean-Michel VallatKarima GhorabCorinne MagdelaineFranck SturtzFrédéric FavreauAnne-Sophie LiaPublished in: Biomedicines (2023)
Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy symptoms using the CovCopCan bioinformatic tool, we discovered the presence of a deletion of around 3kb in ATL3 from Chr11:63,401,422 to Chr11:63,398,182. This deletion affects ATL3 exons 11 and 12 and could lead to the mutation c.(1036-861_1539+329del), p.(Ala346_Gln513del). In addition, an analysis of the breakpoints' sequences revealed the presence of Alu transposable elements at the position of the breakpoints, which pointed to a possible erroneous recombination event following a non-allelic-homologous-recombination mechanism in this area. Moreover, electronic microscopy analysis of the patient's nerve biopsy revealed a severe rarefaction of the myelinated fibers, a demyelinating-remyelinating process, and an abnormal aspect of the endoplasmic reticulum. These findings suggest that this structural variation could potentially be responsible for the HSN symptoms of the patient. Research of structural variations in ATL3 in numerous other patients presenting similar symptoms should be broadly investigated in order to improve patients' diagnoses.
Keyphrases
- case report
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- dna damage
- dna repair
- endoplasmic reticulum
- prognostic factors
- peritoneal dialysis
- early onset
- high throughput
- patient reported outcomes
- mass spectrometry
- electronic health record
- optical coherence tomography
- cancer therapy
- single molecule
- big data